The Horizon for GMP: A Compliance Update
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
When examining the known future for GMP compliance, there are a range of changes that the industry needs to brace for, including a new EU delegated act focused on investigational drug products.
In this infographic, Pharma IQ outlines the GMP updates the market will soon be facing.
Aspects discussed include:
- Future Annex 21 EU GMP Guide
- New Delegated Act impacting GMP for Investigational Medicinal Products for Human Use
- Future Annex 17 of EU GMP Guide Parametric Release
- Annex 1 of EU GMP Guide
- New GMP EU Guideline for Advanced Therapy Medicinal Products
- Transitional QPs and CTs
|Have Your Say|
Rate this feature and give us your feedback in the comments section below
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.